News

GSK plc has announced positive results coming from its two pivotal phase III trials - the B-Well 1 and B-Well 2 phase III trials, assessing bepirovirsen, which is an investigational antisense oligonucleotide - ASO used for the treatment of...

Shortly after going ahead and securing a partnership with Sanofi, InduPro is now linking up with Eli Lilly in its endeavors to discover novel cancer treatments through a pact that could as well be worth almost $950 million. InduPro is...

Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in order to develop oral treatments in obesity as well as other metabolic diseases. Lilly, which very...

When it comes to nutrition, convenience can be demanding. The consumption of ultra-processed food has become a dietary norm because it is easily available and it is flavorful. However, new scientific research findings are becoming increasingly associated with liver...

Weight loss is no longer about the ability to fit into smaller clothes but a matter of serious national health consideration. The World Health Organization estimates that the prevalence of obesity has nearly doubled during the last few decades,...

The European supplement industry has transformed from a niche market serving fitness enthusiasts and health-conscious individuals into a mainstream economic powerhouse. Worth billions of euros and continuing its upward trajectory, this sector has become an integral component of Europe's...

Sanofi and Earendil Labs have announced a strategic collaboration effort that goes on to apply the discovery platform from Earendil across many of the Sanofi autoimmune and inflammatory disease programs. The two AI-powered research and development platforms from Earendil Labs concerning protein therapeutics go on...